KITOZYME
Sources: the KBO register on 22-11-2026; the National Bank, 2025 annual accounts filed on 02-07-2026; the Belgian Official Gazette, latest deed of 30-09-2026.
Grounds
the facts the verdict rests on, each with its source- In 2025, KITOZYME had a turnover of €7.1m and a net profit of €824,661.Annual accounts 2025 page 2
- Equity stands at €17.2m, or 76.9% of the balance sheet total of €22.4m. The solvency of 76.9% is higher than at 78% of the 197 companies filing abbreviated accounts in chemicals (NACE 20) in 2025.Annual accounts 2025 page 2
- Suppliers waited 25 days on average for their money in 2025, 25 days shorter than in 2024. Customers paid after 75 days.Annual accounts 2024 and 2025 page 2
- The last five annual accounts came in on time. The 2025 accounts were filed 29 days before the end of the term.National Bank, filing of 02-07-2026 page 5
Representation
Two directors jointly represent KITOZYME.
Articles of association, Belgian Official Gazette of 17-10-2016, deed 16142835
Ownership
holds 44% of the shares. Its equity stood at €8.8m on 31-12-2025. There are 3 other shareholders.
Annual accounts 2025
Financial situation
Annual accounts 2021 to 2025, as filed with the National Bank
Turnover and net resultin €m
Equity and debtsin €m
Payment termsin days
| Financial year | 2021 | 2022 | 2023 | 2024 | 2025 | Trend |
|---|---|---|---|---|---|---|
| Results | ||||||
| Turnover | €5.4m | €7.7m | €6.8m | €6.7m | €7.1m | |
| Operating result | €4.9m | €1.3m | €942,436 | €831,719 | €666,147 | |
| Net result | €4.8m | €1.5m | €1.2m | €1.1m | €824,661 | |
| Balance sheet at the closing date | ||||||
| Equity | €12.4m | €13.8m | €15.0m | €16.0m | €17.2m | |
| Debts | €5.1m | €4.8m | €4.1m | €4.7m | €4.8m | |
| Debts due after more than one year | €2.3m | €1.4m | €682,448 | €227,800 | €1.1m | |
| Debts due within one year | €2.8m | €3.3m | €3.5m | €4.4m | €3.7m | |
| Cash | €2.8m | €1.6m | €533,599 | €1.3m | €635,010 | |
| Balance sheet total | €17.8m | €18.8m | €19.6m | €21.0m | €22.4m | |
| Operations | ||||||
| Employees in full-time equivalents | 28.6 | 30.5 | 28.2 | 27.3 | 27.2 | |
| Customer credit | 81 days | 107 days | 124 days | 91 days | 75 days | |
| Supplier credit | 62 days | 53 days | 64 days | 50 days | 25 days | |
| Ratios | ||||||
| Solvency | 69.6% | 73.2% | 76.6% | 76.1% | 76.9% | |
| Liquidity | 1.96 | 1.92 | 1.89 | 1.69 | 2.04 | |
Source: Annual accounts 2025, abbreviated format, filed on 02-07-2026 (2026-00264356); Annual accounts 2024, full format, filed on 30-06-2025 (2025-00233376); Annual accounts 2021 to 2023, filed from 28-06-2024 to 09-12-2024 (2024-00616773, 2024-00616584, 2024-00222042).
The operating result of 2025 is 20% lower than in 2024.
The 2025 annual accounts state no amount of overdue tax or social security (RSZ) debts.
Board, signature and ownership
Position on 22-11-2026 according to the deeds in the Belgian Official Gazette and the annual accounts
Who represents the company
Two directors jointly represent KITOZYME.
Articles of association, Belgian Official Gazette of 17-10-2016, deed 16142835
Board
five directors and one statutory auditor in officealso sits on the boards of 8 other companies. also sits on the boards of 252 other companies. also sits on the boards of 253 other companies. also sits on the boards of 3 other companies.
Ownership and group
Shareholders
holds 44% of the shares. Its equity stood at €8.8m on 31-12-2025. holds 18.48% of the shares. Its equity stood at €4.98bn on 31-12-2025. held 18% of the shares. Since the merger of 09-01-2023, these shares have been held by . The equity of stood at €4.98bn on 31-12-2025. There is one other shareholder.
Annual accounts 2025, annual accounts 2025 of
Board changes
, , , , and (statutory auditor). General meeting of 16-06-2026.
Gazette, deed 26121691, and . , and act as permanent representatives. General meeting of 21-06-2024.
Gazette, deed 24153466, and act as permanent representatives. and (statutory auditor). General meeting of 16-06-2023.
Gazette, deed 23129092Holdings
KITOZYME has 2 holdings (own 2025 accounts).
| Country | Company | Equity | Result | |
|---|---|---|---|---|
| Belgium 2 | ||||
| BE | 20% | €9.0m | result €2.2m | |
| BE | 75.88% | €1.1m | result -€1.7m | |
Source: List of holdings in its own 2025 accounts. Every holding stands with its own latest accounts.
Events and comparison
The last 24 months, newest first
Annual accounts 2025 filed, 29 days before the deadline.
NBB filingAnnual accounts 2024 filed, 31 days before the deadline.
NBB filingCorrected annual accounts 2021 filed.
NBB filingCorrected annual accounts 2022 filed.
NBB filingComparable companies, two years later
In July 2024, 14,780 companies had the same profile as KITOZYME has now: small, 20 years or older, solvency 30% or more and a profit under 5% of the balance sheet. Two years later 96.2% were still trading, 3.6% had stopped another way and 0.2% had gone bankrupt.
The return on assets of KITOZYME, 3.7%, is higher than at 49% of the 197 companies filing abbreviated accounts in chemicals (NACE 20) in 2025.
Other findings
Peppol
Reachable for e-invoices, under 0208:0473676932.
Sanctions lists
Staff
29 employees on 31-12-2025, 27.2 full-time equivalents on average over the year.
Sources and method
Where each fact in this report comes from
| Source | What | Date | Reference |
|---|---|---|---|
| KBO register | Registration, legal situation, activity, establishment units | 22-11-2026 | KBO 0473.676.932 |
| National Bank of Belgium | Annual accounts 2025, abbreviated format | 02-07-2026 | 2026-00264356 |
| National Bank of Belgium | Annual accounts 2024, full format | 30-06-2025 | 2025-00233376 |
| National Bank of Belgium | Annual accounts 2021 to 2023 | 28-06-2024 to 09-12-2024 | 2024-00616773, 2024-00616584, 2024-00222042 |
| Belgian Official Gazette | Board | 30-09-2026 | deed 26121691 |
| Belgian Official Gazette | Board | 24-10-2024 | deed 24153466 |
| Belgian Official Gazette | Board | 10-10-2023 | deed 23129092 |
| Belgian Official Gazette | Articles of association with the signing rule | 17-10-2016 | deed 16142835 |
| Peppol Directory | Registration for e-invoices | 0208:0473676932 | |
| Sanctions lists EU, UN, US (OFAC) and UK | Comparison of the name | 19-11-2026 | |
| Checked | Checked score, bankruptcy probability, credit, comparable companies | 21-11-2026 | bankruptcy model of 21 November 2026 |
Method
Checked score. A number from 0 to 100. The bankruptcy probability sets the class, from Critical to Excellent; within the class, the comparison with sector peers on solvency, liquidity, profitability and growth counts for half.
Bankruptcy probability. The probability that the company goes bankrupt within 12 months, estimated from the KBO register, the annual accounts and the Gazette with the bankruptcy model of 21 November 2026, computed on 21-11-2026.
Credit. The credit is a tenth of equity, weighted by the score, and never more than a tenth of turnover. With negative equity there is no credit.
Payment terms. Supplier credit is the debt to suppliers divided by the year's purchases, times 365. Customer credit is the same for what customers still owe, against turnover.
Comparable companies. Companies of the same size, age, solvency and profitability at an earlier date, followed two years later in the KBO register and the Gazette.
The scores and ratios are Checked's own calculations, not a credit decision.